Latvia vs Netherlands: Share of S. aureus infections resistant to methicillin
Latvia
3.8%
in 2022
Netherlands
2.3%
in 2022
Latvia rank
41st
Netherlands rank
42nd
Share of S. aureus infections resistant to methicillin over time
- Latvia
- Netherlands
How they compare
Latvia currently reports 3.8% against 2.3% in Netherlands, a difference of 1.5%.
That makes Latvia's figure about 1.7 times Netherlands's.
Across all 6 years both countries report, Latvia has been ahead every year.
Latvia ranks 41st and Netherlands ranks 42nd of 45 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.6% | 1.4% | 5.1% | Latvia |
| 2020s | 7.3% | 1.8% | 5.5% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Latvia or Netherlands?
- Latvia, at 3.8% against 2.3% in Netherlands as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Latvia and Netherlands?
- 1.5%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Netherlands?
- 6 years are reported by both, from 2017 to 2022.
- How do Latvia and Netherlands rank globally for share of s. aureus infections resistant to methicillin?
- Latvia ranks 41st and Netherlands ranks 42nd of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).